Cite
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.
MLA
Liu, Jinhui, et al. “Exploration of a Novel Prognostic Risk Signatures and Immune Checkpoint Molecules in Endometrial Carcinoma Microenvironment.” Genomics, vol. 112, no. 5, Sept. 2020, pp. 3117–34. EBSCOhost, https://doi.org/10.1016/j.ygeno.2020.05.022.
APA
Liu, J., Nie, S., Wu, Z., Jiang, Y., Wan, Y., Li, S., Meng, H., Zhou, S., & Cheng, W. (2020). Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment. Genomics, 112(5), 3117–3134. https://doi.org/10.1016/j.ygeno.2020.05.022
Chicago
Liu, Jinhui, Sipei Nie, Zhipeng Wu, Yi Jiang, Yicong Wan, Siyue Li, Huangyang Meng, Shulin Zhou, and Wenjun Cheng. 2020. “Exploration of a Novel Prognostic Risk Signatures and Immune Checkpoint Molecules in Endometrial Carcinoma Microenvironment.” Genomics 112 (5): 3117–34. doi:10.1016/j.ygeno.2020.05.022.